References
Spec Sheet

Our Nanex™ IOLs

Proven hydrophobic acrylic lens material:

over 10 million units implanted worldwide, over 20 years1

Significant PCO reduction:

achieved through HOYA’s proprietary active oxygen processing treatment to the posterior surface of the Nanex™ IOL2

Vivinex ImpressTM enhances the intermediate vision of
monofocal patients

Nanex™ multiSert+™ showed a consistent trend towards
stronger PCO inhibition versus AcrySof® IQ across all three scores1,2

In a GLP-study evaluating the PCO of Nanex™ multiSert+™ (NC1-SP) and AcrySof® IQ (SN60WF) in rabbits, while not statistically significant, Nanex™ multiSert+™ showed a trend towards less PCO in comparison with AcrySof® IQ, in the 4-week postoperative study.

Vivinex ImpressTM provides greater than 1 line of
binocular visual acuity improvement at 66cm

What features of an IOL limit PCO?